Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Nature Communications
|
November 8, 2017
Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability
Cornelia Jäkel, Frank Bergmann, Reka Toth, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 15, 2023
Smoking impairs the effect of neoadjuvant FOLFIRINOX on postresection survival in pancreatic cancer
Carl-Stephan Leonhardt, Dietmar Pils, Motaz Qadan, et al.
Annals of Surgery
|
April 12, 2023
The Revised R Status is an Independent Predictor of Postresection Survival in Pancreatic Cancer After Neoadjuvant Treatment
Carl-Stephan Leonhardt, Dietmar Pils, Motaz Qadan, et al.
Endocrine-Related Cancer
|
January 2, 2025
Ampullary composite gangliocytoma/neuroma and neuroendocrine tumor management
Elias Karam, Marcus Hollenbach, Christian Heise, et al.
BJS Open
|
December 1, 2025
Textbook outcome following surgery for pancreatic neuroendocrine tumours: retrospective study
Fabiola A Bechtiger, Zoltan Czigany, Magdalena Lewosinska, et al.
Annals of Surgery
|
June 21, 2024
Preoperative Surgical or Endoscopic Bile Duct Drainage in Pancreatic Cancer
Rosa Klotz, Thomas Hank, Miklos P Berente, et al.
Cancer Research Communications
|
July 29, 2025
Collagen XVII Promotes Pancreatic Ductal Adenocarcinoma Tumor Growth through Regulation of PIK3R5
Thomas Hank, Annie Li, Louisa Bolm, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
March 31, 2020
Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreas
Clifton Rodrigues, Thomas Hank, Motaz Qadan, et al.
Surgery
|
August 5, 2022
Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy
Guoliang Qiao, Crisanta H Ilagan, Carlos Fernandez-Del Castillo, et al.
Journal of the National Cancer Institute
|
February 10, 2016
Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer
Markus A Schirmer, Claudia M Lüske, Sebastian Roppel, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Nature Communications
|
November 8, 2017
Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability
Cornelia Jäkel, Frank Bergmann, Reka Toth, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 15, 2023
Smoking impairs the effect of neoadjuvant FOLFIRINOX on postresection survival in pancreatic cancer
Carl-Stephan Leonhardt, Dietmar Pils, Motaz Qadan, et al.
Annals of Surgery
|
April 12, 2023
The Revised R Status is an Independent Predictor of Postresection Survival in Pancreatic Cancer After Neoadjuvant Treatment
Carl-Stephan Leonhardt, Dietmar Pils, Motaz Qadan, et al.
Endocrine-Related Cancer
|
January 2, 2025
Ampullary composite gangliocytoma/neuroma and neuroendocrine tumor management
Elias Karam, Marcus Hollenbach, Christian Heise, et al.
BJS Open
|
December 1, 2025
Textbook outcome following surgery for pancreatic neuroendocrine tumours: retrospective study
Fabiola A Bechtiger, Zoltan Czigany, Magdalena Lewosinska, et al.
Annals of Surgery
|
June 21, 2024
Preoperative Surgical or Endoscopic Bile Duct Drainage in Pancreatic Cancer
Rosa Klotz, Thomas Hank, Miklos P Berente, et al.
Cancer Research Communications
|
July 29, 2025
Collagen XVII Promotes Pancreatic Ductal Adenocarcinoma Tumor Growth through Regulation of PIK3R5
Thomas Hank, Annie Li, Louisa Bolm, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
March 31, 2020
Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreas
Clifton Rodrigues, Thomas Hank, Motaz Qadan, et al.
Surgery
|
August 5, 2022
Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy
Guoliang Qiao, Crisanta H Ilagan, Carlos Fernandez-Del Castillo, et al.
Journal of the National Cancer Institute
|
February 10, 2016
Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer
Markus A Schirmer, Claudia M Lüske, Sebastian Roppel, et al.
Page
of 7